Correction to: BRAF Inhibitor Resistance in Meslanoma: Mechanisms and Alternative Therapeutic Strategies
Curr Treat Options Oncol
.
2022 Dec;23(12):1877-1878.
doi: 10.1007/s11864-022-01038-z.
Authors
Jingqin Zhong
1
,
Wangjun Yan
1
,
Chunmeng Wang
1
,
Wanlin Liu
1
,
Xinyi Lin
1
,
Zijian Zou
1
,
Wei Sun
2
,
Yong Chen
3
Affiliations
1
Department of Musculoskeletal Oncology, Fudan University Shanghai Cancer Center, 270 Dongan Road, Xuhui, Shanghai, China.
2
Department of Musculoskeletal Oncology, Fudan University Shanghai Cancer Center, 270 Dongan Road, Xuhui, Shanghai, China. wsun14@fudan.edu.cn.
3
Department of Musculoskeletal Oncology, Fudan University Shanghai Cancer Center, 270 Dongan Road, Xuhui, Shanghai, China. chenyong@fudan.edu.cn.
PMID:
36459337
PMCID:
PMC9767990
DOI:
10.1007/s11864-022-01038-z
No abstract available
Publication types
Published Erratum